Hormetic Priming-Repair Decoupling: Why Stress-Induced Cholinergic Preservation Fails to Outlast the Stressor

Hypothesis

Hormetic stressors such as caloric restriction or exercise preserve cholinergic basal forebrain structure by transiently inhibiting anabolic signaling (e.g., mTORC1) and activating catabolic stress pathways (AMPK, HIF‑1α). This state protects neurons from damage but does not engage the molecular machinery required for axonal repair. True repair of NGF retrograde transport and cholinergic varicosity reactivation depends on a recovery phase in which mTORC1 is re‑activated, allowing protein synthesis, mitochondrial biogenesis, and trophic‑factor trafficking. Without such a recovery window, the protective effect collapses once the stressor is removed, revealing that hormesis sustains a threat‑response mode rather than initiating lasting repair.

Mechanistic Basis

1. Stress‑induced AMPK/HIF-1α activation → phosphorylation of TSC2 and REDD1 → suppression of mTORC1 → reduced global translation and axonal growth.
2. Concurrent ROS mitigation → activation of Nrf2 and SOD2 lowers oxidative damage, preserving ChAT activity and varicosity density (see [1][2][3]).
3. Repair requirement → mTORC1‑dependent synthesis of cytoskeletal proteins (e.g., tau, neurofilament), vesicle‑traffic machinery (kinesin‑1, dynein), and NGF‑TrkA complexes is essential for retrograde transport restoration ([4]).
4. Decoupling → hormesis provides step 2 but maintains step 1, blocking step 3; only when stress ceases and nutrients rebound (re‑feeding, post‑exercise rest) does mTORC1 reactivate, permitting repair.

Testable Predictions

• If cholinergic preservation under hormesis is purely a threat response, then withdrawing the stressor without providing an anabolic cue will cause a rapid decline in NGF‑TrkA retrograde transport and varicosity density to baseline aged levels, despite continued low oxidative stress.
• Providing an anabolic stimulus (e.g., leucine‑rich diet, IGF‑1 infusion) during the withdrawal phase will rescue transport function and varicosity density beyond what oxidative‑stress reduction alone can achieve.
• In neurons where mTORC1 is genetically kept inhibited (e.g., Raptor knockdown) during hormetic exposure, cholinergic markers will be preserved but transport will remain impaired even after stressor removal.
• Conversely, forced mTORC1 activation (Rheb overexpression) during hormesis will accelerate repair, leading to super‑youthful transport rates that persist after stressor cessation.

Experimental Design

1. Animal model – 18‑month‑old male rats receive 6‑month‑old onset 60 % caloric restriction (CR) or voluntary wheel running.
2. Withdrawal phase – After 6 months, animals are returned to ad libitum feeding (CR) or locked wheels (exercise) for 4 weeks; subgroups receive leucine supplementation (2 % w/w) or IGF‑1 (via osmotic pump) during withdrawal.
3. Readouts – (a) In vivo PET with radiolabeled NGF to quantify retrograde transport; (b) Choline acetyltransferase immunoreactivity and varicosity count in hippocampus; (c) mitochondrial ROS (MitoSOX) and phospho‑S6K (mTORC1 activity) in basal forebrain lysates.
4. Controls – Age‑matched ad libitum sedentary rats; rapamycin‑treated CR animals to maintain mTORC1 inhibition; Rheb‑overexpressing viral vector in a subset.
5. Analysis – Two‑way ANOVA (stress × recovery) with post‑hoc tests; significance set at p<0.05.

Expected Outcome

If the hypothesis is correct, withdrawal alone will reduce NGF transport to aged levels despite low oxidative stress; leucine/IGF‑1 will preserve or enhance transport; rapamycin will block rescue; Rheb will produce sustained super‑youthful transport. This would demonstrate that hormesis preserves cholinergic structure via stress‑response pathways but requires a separate anabolic recovery to enact genuine repair, directly challenging the idea that hormesis itself is a longevity mechanism.

References

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC4259091/ [2] https://pubmed.ncbi.nlm.nih.gov/16472476/ [3] https://elifesciences.org/articles/32018 [4] https://pubmed.ncbi.nlm.nih.gov/11229357/